Global Poliovirus Vaccine Inactivated Market Growth 2022-2028

1.1 Market Introduction

1.2 Years Considered

1.3 Research Objectives

1.4 Market Research Methodology

1.5 Research Process and Data Source

1.6 Economic Indicators

1.7 Currency Considered

2 Executive Summary

2.1 World Market Overview

2.1.1 Global Poliovirus Vaccine Inactivated Annual Sales 2017-2028

2.1.2 World Current & Future Analysis for Poliovirus Vaccine Inactivated by Geographic Region, 2017, 2022 & 2028

2.1.3 World Current & Future Analysis for Poliovirus Vaccine Inactivated by Country/Region, 2017, 2022 & 2028

2.2 Poliovirus Vaccine Inactivated Segment by Type

2.2.1 Human Diploid Cell

2.2.2 Monkey Kidney Cell

2.3 Poliovirus Vaccine Inactivated Sales by Type

2.3.1 Global Poliovirus Vaccine Inactivated Sales Market Share by Type (2017-2022)

2.3.2 Global Poliovirus Vaccine Inactivated Revenue and Market Share by Type (2017-2022)

2.3.3 Global Poliovirus Vaccine Inactivated Sale Price by Type (2017-2022)

2.4 Poliovirus Vaccine Inactivated Segment by Application

2.4.1 Public

2.4.2 Private

2.5 Poliovirus Vaccine Inactivated Sales by Application

2.5.1 Global Poliovirus Vaccine Inactivated Sale Market Share by Application (2017-2022)

2.5.2 Global Poliovirus Vaccine Inactivated Revenue and Market Share by Application (2017-2022)

2.5.3 Global Poliovirus Vaccine Inactivated Sale Price by Application (2017-2022)

3 Global Poliovirus Vaccine Inactivated by Company

3.1 Global Poliovirus Vaccine Inactivated Breakdown Data by Company

3.1.1 Global Poliovirus Vaccine Inactivated Annual Sales by Company (2020-2022)

3.1.2 Global Poliovirus Vaccine Inactivated Sales Market Share by Company (2020-2022)

3.2 Global Poliovirus Vaccine Inactivated Annual Revenue by Company (2020-2022)

3.2.1 Global Poliovirus Vaccine Inactivated Revenue by Company (2020-2022)

3.2.2 Global Poliovirus Vaccine Inactivated Revenue Market Share by Company (2020-2022)

3.3 Global Poliovirus Vaccine Inactivated Sale Price by Company

3.4 Key Manufacturers Poliovirus Vaccine Inactivated Producing Area Distribution, Sales Area, Product Type

3.4.1 Key Manufacturers Poliovirus Vaccine Inactivated Product Location Distribution

3.4.2 Players Poliovirus Vaccine Inactivated Products Offered

3.5 Market Concentration Rate Analysis

3.5.1 Competition Landscape Analysis

3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)

3.6 New Products and Potential Entrants

3.7 Mergers & Acquisitions, Expansion

4 World Historic Review for Poliovirus Vaccine Inactivated by Geographic Region

4.1 World Historic Poliovirus Vaccine Inactivated Market Size by Geographic Region (2017-2022)

4.1.1 Global Poliovirus Vaccine Inactivated Annual Sales by Geographic Region (2017-2022)

4.1.2 Global Poliovirus Vaccine Inactivated Annual Revenue by Geographic Region

4.2 World Historic Poliovirus Vaccine Inactivated Market Size by Country/Region (2017-2022)

4.2.1 Global Poliovirus Vaccine Inactivated Annual Sales by Country/Region (2017-2022)

4.2.2 Global Poliovirus Vaccine Inactivated Annual Revenue by Country/Region

4.3 Americas Poliovirus Vaccine Inactivated Sales Growth

4.4 APAC Poliovirus Vaccine Inactivated Sales Growth

4.5 Europe Poliovirus Vaccine Inactivated Sales Growth

4.6 Middle East & Africa Poliovirus Vaccine Inactivated Sales Growth

5 Americas

5.1 Americas Poliovirus Vaccine Inactivated Sales by Country

5.1.1 Americas Poliovirus Vaccine Inactivated Sales by Country (2017-2022)

5.1.2 Americas Poliovirus Vaccine Inactivated Revenue by Country (2017-2022)

5.2 Americas Poliovirus Vaccine Inactivated Sales by Type

5.3 Americas Poliovirus Vaccine Inactivated Sales by Application

5.4 United States

5.5 Canada

5.6 Mexico

5.7 Brazil

6 APAC

6.1 APAC Poliovirus Vaccine Inactivated Sales by Region

6.1.1 APAC Poliovirus Vaccine Inactivated Sales by Region (2017-2022)

6.1.2 APAC Poliovirus Vaccine Inactivated Revenue by Region (2017-2022)

6.2 APAC Poliovirus Vaccine Inactivated Sales by Type

6.3 APAC Poliovirus Vaccine Inactivated Sales by Application

6.4 China

6.5 Japan

6.6 South Korea

6.7 Southeast Asia

6.8 India

6.9 Australia

6.10 China Taiwan

7 Europe

7.1 Europe Poliovirus Vaccine Inactivated by Country

7.1.1 Europe Poliovirus Vaccine Inactivated Sales by Country (2017-2022)

7.1.2 Europe Poliovirus Vaccine Inactivated Revenue by Country (2017-2022)

7.2 Europe Poliovirus Vaccine Inactivated Sales by Type

7.3 Europe Poliovirus Vaccine Inactivated Sales by Application

7.4 Germany

7.5 France

7.6 UK

7.7 Italy

7.8 Russia

8 Middle East & Africa

8.1 Middle East & Africa Poliovirus Vaccine Inactivated by Country

8.1.1 Middle East & Africa Poliovirus Vaccine Inactivated Sales by Country (2017-2022)

8.1.2 Middle East & Africa Poliovirus Vaccine Inactivated Revenue by Country (2017-2022)

8.2 Middle East & Africa Poliovirus Vaccine Inactivated Sales by Type

8.3 Middle East & Africa Poliovirus Vaccine Inactivated Sales by Application

8.4 Egypt

8.5 South Africa

8.6 Israel

8.7 Turkey

8.8 GCC Countries

9 Market Drivers, Challenges and Trends

9.1 Market Drivers & Growth Opportunities

9.2 Market Challenges & Risks

9.3 Industry Trends

10 Manufacturing Cost Structure Analysis

10.1 Raw Material and Suppliers

10.2 Manufacturing Cost Structure Analysis of Poliovirus Vaccine Inactivated

10.3 Manufacturing Process Analysis of Poliovirus Vaccine Inactivated

10.4 Industry Chain Structure of Poliovirus Vaccine Inactivated

11 Marketing, Distributors and Customer

11.1 Sales Channel

11.1.1 Direct Channels

11.1.2 Indirect Channels

11.2 Poliovirus Vaccine Inactivated Distributors

11.3 Poliovirus Vaccine Inactivated Customer

12 World Forecast Review for Poliovirus Vaccine Inactivated by Geographic Region

12.1 Global Poliovirus Vaccine Inactivated Market Size Forecast by Region

12.1.1 Global Poliovirus Vaccine Inactivated Forecast by Region (2023-2028)

12.1.2 Global Poliovirus Vaccine Inactivated Annual Revenue Forecast by Region (2023-2028)

12.2 Americas Forecast by Country

12.3 APAC Forecast by Region

12.4 Europe Forecast by Country

12.5 Middle East & Africa Forecast by Country

12.6 Global Poliovirus Vaccine Inactivated Forecast by Type

12.7 Global Poliovirus Vaccine Inactivated Forecast by Application

13 Key Players Analysis

13.1 Sanofi

13.1.1 Sanofi Company Information

13.1.2 Sanofi Poliovirus Vaccine Inactivated Product Offered

13.1.3 Sanofi Poliovirus Vaccine Inactivated Sales, Revenue, Price and Gross Margin (2020-2022)

13.1.4 Sanofi Main Business Overview

13.1.5 Sanofi Latest Developments

13.2 GSK

13.2.1 GSK Company Information

13.2.2 GSK Poliovirus Vaccine Inactivated Product Offered

13.2.3 GSK Poliovirus Vaccine Inactivated Sales, Revenue, Price and Gross Margin (2020-2022)

13.2.4 GSK Main Business Overview

13.2.5 GSK Latest Developments

13.3 Serum Institute (Bilthoven Biologicals)

13.3.1 Serum Institute (Bilthoven Biologicals) Company Information

13.3.2 Serum Institute (Bilthoven Biologicals) Poliovirus Vaccine Inactivated Product Offered

13.3.3 Serum Institute (Bilthoven Biologicals) Poliovirus Vaccine Inactivated Sales, Revenue, Price and Gross Margin (2020-2022)

13.3.4 Serum Institute (Bilthoven Biologicals) Main Business Overview

13.3.5 Serum Institute (Bilthoven Biologicals) Latest Developments

13.4 IMBCA

13.4.1 IMBCA Company Information

13.4.2 IMBCA Poliovirus Vaccine Inactivated Product Offered

13.4.3 IMBCA Poliovirus Vaccine Inactivated Sales, Revenue, Price and Gross Margin (2020-2022)

13.4.4 IMBCA Main Business Overview

13.4.5 IMBCA Latest Developments

14 Research Findings and Conclusion

Table 1. Poliovirus Vaccine Inactivated Annual Sales CAGR by Geographic Region (2017, 2022 & 2028) & ($ millions)

Table 2. Poliovirus Vaccine Inactivated Annual Sales CAGR by Country/Region (2017, 2022 & 2028) & ($ millions)

Table 3. Major Players of Human Diploid Cell

Table 4. Major Players of Monkey Kidney Cell

Table 5. Global Poliovirus Vaccine Inactivated Sales by Type (2017-2022) & (K Units)

Table 6. Global Poliovirus Vaccine Inactivated Sales Market Share by Type (2017-2022)

Table 7. Global Poliovirus Vaccine Inactivated Revenue by Type (2017-2022) & ($ million)

Table 8. Global Poliovirus Vaccine Inactivated Revenue Market Share by Type (2017-2022)

Table 9. Global Poliovirus Vaccine Inactivated Sale Price by Type (2017-2022) & (USD/Unit)

Table 10. Global Poliovirus Vaccine Inactivated Sales by Application (2017-2022) & (K Units)

Table 11. Global Poliovirus Vaccine Inactivated Sales Market Share by Application (2017-2022)

Table 12. Global Poliovirus Vaccine Inactivated Revenue by Application (2017-2022)

Table 13. Global Poliovirus Vaccine Inactivated Revenue Market Share by Application (2017-2022)

Table 14. Global Poliovirus Vaccine Inactivated Sale Price by Application (2017-2022) & (USD/Unit)

Table 15. Global Poliovirus Vaccine Inactivated Sales by Company (2020-2022) & (K Units)

Table 16. Global Poliovirus Vaccine Inactivated Sales Market Share by Company (2020-2022)

Table 17. Global Poliovirus Vaccine Inactivated Revenue by Company (2020-2022) ($ Millions)

Table 18. Global Poliovirus Vaccine Inactivated Revenue Market Share by Company (2020-2022)

Table 19. Global Poliovirus Vaccine Inactivated Sale Price by Company (2020-2022) & (USD/Unit)

Table 20. Key Manufacturers Poliovirus Vaccine Inactivated Producing Area Distribution and Sales Area

Table 21. Players Poliovirus Vaccine Inactivated Products Offered

Table 22. Poliovirus Vaccine Inactivated Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)

Table 23. New Products and Potential Entrants

Table 24. Mergers & Acquisitions, Expansion

Table 25. Global Poliovirus Vaccine Inactivated Sales by Geographic Region (2017-2022) & (K Units)

Table 26. Global Poliovirus Vaccine Inactivated Sales Market Share Geographic Region (2017-2022)

Table 27. Global Poliovirus Vaccine Inactivated Revenue by Geographic Region (2017-2022) & ($ millions)

Table 28. Global Poliovirus Vaccine Inactivated Revenue Market Share by Geographic Region (2017-2022)

Table 29. Global Poliovirus Vaccine Inactivated Sales by Country/Region (2017-2022) & (K Units)

Table 30. Global Poliovirus Vaccine Inactivated Sales Market Share by Country/Region (2017-2022)

Table 31. Global Poliovirus Vaccine Inactivated Revenue by Country/Region (2017-2022) & ($ millions)

Table 32. Global Poliovirus Vaccine Inactivated Revenue Market Share by Country/Region (2017-2022)

Table 33. Americas Poliovirus Vaccine Inactivated Sales by Country (2017-2022) & (K Units)

Table 34. Americas Poliovirus Vaccine Inactivated Sales Market Share by Country (2017-2022)

Table 35. Americas Poliovirus Vaccine Inactivated Revenue by Country (2017-2022) & ($ Millions)

Table 36. Americas Poliovirus Vaccine Inactivated Revenue Market Share by Country (2017-2022)

Table 37. Americas Poliovirus Vaccine Inactivated Sales by Type (2017-2022) & (K Units)

Table 38. Americas Poliovirus Vaccine Inactivated Sales Market Share by Type (2017-2022)

Table 39. Americas Poliovirus Vaccine Inactivated Sales by Application (2017-2022) & (K Units)

Table 40. Americas Poliovirus Vaccine Inactivated Sales Market Share by Application (2017-2022)

Table 41. APAC Poliovirus Vaccine Inactivated Sales by Region (2017-2022) & (K Units)

Table 42. APAC Poliovirus Vaccine Inactivated Sales Market Share by Region (2017-2022)

Table 43. APAC Poliovirus Vaccine Inactivated Revenue by Region (2017-2022) & ($ Millions)

Table 44. APAC Poliovirus Vaccine Inactivated Revenue Market Share by Region (2017-2022)

Table 45. APAC Poliovirus Vaccine Inactivated Sales by Type (2017-2022) & (K Units)

Table 46. APAC Poliovirus Vaccine Inactivated Sales Market Share by Type (2017-2022)

Table 47. APAC Poliovirus Vaccine Inactivated Sales by Application (2017-2022) & (K Units)

Table 48. APAC Poliovirus Vaccine Inactivated Sales Market Share by Application (2017-2022)

Table 49. Europe Poliovirus Vaccine Inactivated Sales by Country (2017-2022) & (K Units)

Table 50. Europe Poliovirus Vaccine Inactivated Sales Market Share by Country (2017-2022)

Table 51. Europe Poliovirus Vaccine Inactivated Revenue by Country (2017-2022) & ($ Millions)

Table 52. Europe Poliovirus Vaccine Inactivated Revenue Market Share by Country (2017-2022)

Table 53. Europe Poliovirus Vaccine Inactivated Sales by Type (2017-2022) & (K Units)

Table 54. Europe Poliovirus Vaccine Inactivated Sales Market Share by Type (2017-2022)

Table 55. Europe Poliovirus Vaccine Inactivated Sales by Application (2017-2022) & (K Units)

Table 56. Europe Poliovirus Vaccine Inactivated Sales Market Share by Application (2017-2022)

Table 57. Middle East & Africa Poliovirus Vaccine Inactivated Sales by Country (2017-2022) & (K Units)

Table 58. Middle East & Africa Poliovirus Vaccine Inactivated Sales Market Share by Country (2017-2022)

Table 59. Middle East & Africa Poliovirus Vaccine Inactivated Revenue by Country (2017-2022) & ($ Millions)

Table 60. Middle East & Africa Poliovirus Vaccine Inactivated Revenue Market Share by Country (2017-2022)

Table 61. Middle East & Africa Poliovirus Vaccine Inactivated Sales by Type (2017-2022) & (K Units)

Table 62. Middle East & Africa Poliovirus Vaccine Inactivated Sales Market Share by Type (2017-2022)

Table 63. Middle East & Africa Poliovirus Vaccine Inactivated Sales by Application (2017-2022) & (K Units)

Table 64. Middle East & Africa Poliovirus Vaccine Inactivated Sales Market Share by Application (2017-2022)

Table 65. Key Market Drivers & Growth Opportunities of Poliovirus Vaccine Inactivated

Table 66. Key Market Challenges & Risks of Poliovirus Vaccine Inactivated

Table 67. Key Industry Trends of Poliovirus Vaccine Inactivated

Table 68. Poliovirus Vaccine Inactivated Raw Material

Table 69. Key Suppliers of Raw Materials

Table 70. Poliovirus Vaccine Inactivated Distributors List

Table 71. Poliovirus Vaccine Inactivated Customer List

Table 72. Global Poliovirus Vaccine Inactivated Sales Forecast by Region (2023-2028) & (K Units)

Table 73. Global Poliovirus Vaccine Inactivated Sales Market Forecast by Region

Table 74. Global Poliovirus Vaccine Inactivated Revenue Forecast by Region (2023-2028) & ($ millions)

Table 75. Global Poliovirus Vaccine Inactivated Revenue Market Share Forecast by Region (2023-2028)

Table 76. Americas Poliovirus Vaccine Inactivated Sales Forecast by Country (2023-2028) & (K Units)

Table 77. Americas Poliovirus Vaccine Inactivated Revenue Forecast by Country (2023-2028) & ($ millions)

Table 78. APAC Poliovirus Vaccine Inactivated Sales Forecast by Region (2023-2028) & (K Units)

Table 79. APAC Poliovirus Vaccine Inactivated Revenue Forecast by Region (2023-2028) & ($ millions)

Table 80. Europe Poliovirus Vaccine Inactivated Sales Forecast by Country (2023-2028) & (K Units)

Table 81. Europe Poliovirus Vaccine Inactivated Revenue Forecast by Country (2023-2028) & ($ millions)

Table 82. Middle East & Africa Poliovirus Vaccine Inactivated Sales Forecast by Country (2023-2028) & (K Units)

Table 83. Middle East & Africa Poliovirus Vaccine Inactivated Revenue Forecast by Country (2023-2028) & ($ millions)

Table 84. Global Poliovirus Vaccine Inactivated Sales Forecast by Type (2023-2028) & (K Units)

Table 85. Global Poliovirus Vaccine Inactivated Sales Market Share Forecast by Type (2023-2028)

Table 86. Global Poliovirus Vaccine Inactivated Revenue Forecast by Type (2023-2028) & ($ Millions)

Table 87. Global Poliovirus Vaccine Inactivated Revenue Market Share Forecast by Type (2023-2028)

Table 88. Global Poliovirus Vaccine Inactivated Sales Forecast by Application (2023-2028) & (K Units)

Table 89. Global Poliovirus Vaccine Inactivated Sales Market Share Forecast by Application (2023-2028)

Table 90. Global Poliovirus Vaccine Inactivated Revenue Forecast by Application (2023-2028) & ($ Millions)

Table 91. Global Poliovirus Vaccine Inactivated Revenue Market Share Forecast by Application (2023-2028)

Table 92. Sanofi Basic Information, Poliovirus Vaccine Inactivated Manufacturing Base, Sales Area and Its Competitors

Table 93. Sanofi Poliovirus Vaccine Inactivated Product Offered

Table 94. Sanofi Poliovirus Vaccine Inactivated Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 95. Sanofi Main Business

Table 96. Sanofi Latest Developments

Table 97. GSK Basic Information, Poliovirus Vaccine Inactivated Manufacturing Base, Sales Area and Its Competitors

Table 98. GSK Poliovirus Vaccine Inactivated Product Offered

Table 99. GSK Poliovirus Vaccine Inactivated Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 100. GSK Main Business

Table 101. GSK Latest Developments

Table 102. Serum Institute (Bilthoven Biologicals) Basic Information, Poliovirus Vaccine Inactivated Manufacturing Base, Sales Area and Its Competitors

Table 103. Serum Institute (Bilthoven Biologicals) Poliovirus Vaccine Inactivated Product Offered

Table 104. Serum Institute (Bilthoven Biologicals) Poliovirus Vaccine Inactivated Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 105. Serum Institute (Bilthoven Biologicals) Main Business

Table 106. Serum Institute (Bilthoven Biologicals) Latest Developments

Table 107. IMBCA Basic Information, Poliovirus Vaccine Inactivated Manufacturing Base, Sales Area and Its Competitors

Table 108. IMBCA Poliovirus Vaccine Inactivated Product Offered

Table 109. IMBCA Poliovirus Vaccine Inactivated Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 110. IMBCA Main Business

Table 111. IMBCA Latest Developments

List of Figures

Figure 1. Picture of Poliovirus Vaccine Inactivated

Figure 2. Poliovirus Vaccine Inactivated Report Years Considered

Figure 3. Research Objectives

Figure 4. Research Methodology

Figure 5. Research Process and Data Source

Figure 6. Global Poliovirus Vaccine Inactivated Sales Growth Rate 2017-2028 (K Units)

Figure 7. Global Poliovirus Vaccine Inactivated Revenue Growth Rate 2017-2028 ($ Millions)

Figure 8. Poliovirus Vaccine Inactivated Sales by Region (2021 & 2028) & ($ millions)

Figure 9. Product Picture of Human Diploid Cell

Figure 10. Product Picture of Monkey Kidney Cell

Figure 11. Global Poliovirus Vaccine Inactivated Sales Market Share by Type in 2021

Figure 12. Global Poliovirus Vaccine Inactivated Revenue Market Share by Type (2017-2022)

Figure 13. Poliovirus Vaccine Inactivated Consumed in Public

Figure 14. Global Poliovirus Vaccine Inactivated Market: Public (2017-2022) & (K Units)

Figure 15. Poliovirus Vaccine Inactivated Consumed in Private

Figure 16. Global Poliovirus Vaccine Inactivated Market: Private (2017-2022) & (K Units)

Figure 17. Global Poliovirus Vaccine Inactivated Sales Market Share by Application (2017-2022)

Figure 18. Global Poliovirus Vaccine Inactivated Revenue Market Share by Application in 2021

Figure 19. Poliovirus Vaccine Inactivated Revenue Market by Company in 2021 ($ Million)

Figure 20. Global Poliovirus Vaccine Inactivated Revenue Market Share by Company in 2021

Figure 21. Global Poliovirus Vaccine Inactivated Sales Market Share by Geographic Region (2017-2022)

Figure 22. Global Poliovirus Vaccine Inactivated Revenue Market Share by Geographic Region in 2021

Figure 23. Global Poliovirus Vaccine Inactivated Sales Market Share by Region (2017-2022)

Figure 24. Global Poliovirus Vaccine Inactivated Revenue Market Share by Country/Region in 2021

Figure 25. Americas Poliovirus Vaccine Inactivated Sales 2017-2022 (K Units)

Figure 26. Americas Poliovirus Vaccine Inactivated Revenue 2017-2022 ($ Millions)

Figure 27. APAC Poliovirus Vaccine Inactivated Sales 2017-2022 (K Units)

Figure 28. APAC Poliovirus Vaccine Inactivated Revenue 2017-2022 ($ Millions)

Figure 29. Europe Poliovirus Vaccine Inactivated Sales 2017-2022 (K Units)

Figure 30. Europe Poliovirus Vaccine Inactivated Revenue 2017-2022 ($ Millions)

Figure 31. Middle East & Africa Poliovirus Vaccine Inactivated Sales 2017-2022 (K Units)

Figure 32. Middle East & Africa Poliovirus Vaccine Inactivated Revenue 2017-2022 ($ Millions)

Figure 33. Americas Poliovirus Vaccine Inactivated Sales Market Share by Country in 2021

Figure 34. Americas Poliovirus Vaccine Inactivated Revenue Market Share by Country in 2021

Figure 35. United States Poliovirus Vaccine Inactivated Revenue Growth 2017-2022 ($ Millions)

Figure 36. Canada Poliovirus Vaccine Inactivated Revenue Growth 2017-2022 ($ Millions)

Figure 37. Mexico Poliovirus Vaccine Inactivated Revenue Growth 2017-2022 ($ Millions)

Figure 38. Brazil Poliovirus Vaccine Inactivated Revenue Growth 2017-2022 ($ Millions)

Figure 39. APAC Poliovirus Vaccine Inactivated Sales Market Share by Region in 2021

Figure 40. APAC Poliovirus Vaccine Inactivated Revenue Market Share by Regions in 2021

Figure 41. China Poliovirus Vaccine Inactivated Revenue Growth 2017-2022 ($ Millions)

Figure 42. Japan Poliovirus Vaccine Inactivated Revenue Growth 2017-2022 ($ Millions)

Figure 43. South Korea Poliovirus Vaccine Inactivated Revenue Growth 2017-2022 ($ Millions)

Figure 44. Southeast Asia Poliovirus Vaccine Inactivated Revenue Growth 2017-2022 ($ Millions)

Figure 45. India Poliovirus Vaccine Inactivated Revenue Growth 2017-2022 ($ Millions)

Figure 46. Australia Poliovirus Vaccine Inactivated Revenue Growth 2017-2022 ($ Millions)

Figure 47. Europe Poliovirus Vaccine Inactivated Sales Market Share by Country in 2021

Figure 48. Europe Poliovirus Vaccine Inactivated Revenue Market Share by Country in 2021

Figure 49. Germany Poliovirus Vaccine Inactivated Revenue Growth 2017-2022 ($ Millions)

Figure 50. France Poliovirus Vaccine Inactivated Revenue Growth 2017-2022 ($ Millions)

Figure 51. UK Poliovirus Vaccine Inactivated Revenue Growth 2017-2022 ($ Millions)

Figure 52. Italy Poliovirus Vaccine Inactivated Revenue Growth 2017-2022 ($ Millions)

Figure 53. Russia Poliovirus Vaccine Inactivated Revenue Growth 2017-2022 ($ Millions)

Figure 54. Middle East & Africa Poliovirus Vaccine Inactivated Sales Market Share by Country in 2021

Figure 55. Middle East & Africa Poliovirus Vaccine Inactivated Revenue Market Share by Country in 2021

Figure 56. Egypt Poliovirus Vaccine Inactivated Revenue Growth 2017-2022 ($ Millions)

Figure 57. South Africa Poliovirus Vaccine Inactivated Revenue Growth 2017-2022 ($ Millions)

Figure 58. Israel Poliovirus Vaccine Inactivated Revenue Growth 2017-2022 ($ Millions)

Figure 59. Turkey Poliovirus Vaccine Inactivated Revenue Growth 2017-2022 ($ Millions)

Figure 60. GCC Country Poliovirus Vaccine Inactivated Revenue Growth 2017-2022 ($ Millions)

Figure 61. Manufacturing Cost Structure Analysis of Poliovirus Vaccine Inactivated in 2021

Figure 62. Manufacturing Process Analysis of Poliovirus Vaccine Inactivated

Figure 63. Industry Chain Structure of Poliovirus Vaccine Inactivated

Figure 64. Channels of Distribution

Figure 65. Distributors Profiles